Category Archives: Best Performing Analysts
RBC Capital Sticks to Their Hold Rating for SAP AG
RBC Capital analyst Ross MacMillan reiterated a Hold rating on SAP AG (NYSE: SAP) yesterday and set a price target of $122. The company’s shares closed yesterday at $108.50. According to TipRanks.com, MacMillan is a top 25 analyst with an
Oppenheimer Reaffirms Their Hold Rating on Total System Services
Oppenheimer analyst Glenn Greene maintained a Hold rating on Total System Services (NYSE: TSS) yesterday. The company’s shares closed yesterday at $85.61, close to its 52-week high of $90.74. Greene wrote: “TSS reported another solid upside quarter, with reported net
Amgen Inc Gets a Buy Rating from Cowen & Co.
Cowen & Co. analyst Eric Schmidt maintained a Buy rating on Amgen Inc (NASDAQ: AMGN) today and set a price target of $204. The company’s shares opened today at $171.94. According to TipRanks.com, Schmidt is a top 25 analyst with
Analysts’ Top Healthcare Picks: DRNA, EPZM
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Dicerna Pharma (NASDAQ: DRNA) and Epizyme (NASDAQ: EPZM) with bullish sentiments. Dicerna Pharma (NASDAQ: DRNA) In a report released yesterday, Ritu Baral
Staar Surgical Company Receives a Buy from Canaccord Genuity
In a report released today, Jason Mills from Canaccord Genuity reiterated a Buy rating on Staar Surgical Company (NASDAQ: STAA), with a price target of $21. The company’s shares opened today at $16.15. Mills observed: “We hosted CEO Caren Mason
Cowen & Co. Thinks Biogen Inc’s Stock is Going to Recover
In a report released today, Eric Schmidt from Cowen & Co. assigned a Buy rating to Biogen Inc (NASDAQ: BIIB), with a price target of $408. The company’s shares opened today at $253.71, close to its 52-week low of $244.28.
